10-Q: Performant Healthcare Reports Q1 2025 Results: Revenue Surges, Losses Narrow
Quarterly Report
Performant Healthcare's Q1 2025 shows a significant revenue increase and a substantial reduction in net loss compared to the same period last year.
Summary
- Performant Healthcare, Inc. reported its financial results for the quarter ended March 31, 2025.
- Revenues increased by 22% to $33.3 million, compared to $27.3 million in Q1 2024.
- Healthcare revenues rose by 29% to $33.2 million, driven by growth in both eligibility-based and claims-based services.
- Eligibility-based revenues increased by 20% to $16.1 million, while claims-based revenues increased by 38% to $17.1 million.
- Customer Care / Outsourced Services revenues decreased by 95% to $0.1 million due to the cessation of outsourced services.
- Salaries and benefits expense increased by 9% to $25.4 million, supporting the growth in healthcare services.
- Other operating expenses decreased slightly to $7.8 million.
- The company reported income from operations of $0.2 million, compared to a loss from operations of $3.9 million in Q1 2024.
- Net loss decreased significantly to $81 thousand, compared to a net loss of $4.0 million in Q1 2024.
- Adjusted EBITDA was $3.3 million, compared to $(1.2) million in the prior year.
- The company had $10.0 million in cash and cash equivalents as of March 31, 2025, compared to $9.3 million as of December 31, 2024.
- $8.0 million was outstanding under the Credit Agreement, with $14.2 million of additional borrowings available.
Sentiment
Score: 7
Explanation: The document presents a positive outlook with significant revenue growth and a substantial reduction in net loss. While there are risks, the overall tone is optimistic.
Positives
- Significant revenue growth of 22% year-over-year.
- Substantial reduction in net loss, indicating improved profitability.
- Strong growth in healthcare revenues, particularly in claims-based services.
- Improved Adjusted EBITDA, reflecting better operational performance.
- The company has available liquidity through its credit agreement.
Negatives
- Customer Care / Outsourced Services revenues decreased significantly due to the cessation of outsourced services.
- Salaries and benefits expense increased, although this was in support of revenue growth.
- The company still reported a net loss, albeit a small one.
Risks
- The company faces risks related to long implementation periods for new contracts.
- A significant portion of revenues is derived from a limited number of large clients.
- The company operates in a highly competitive market.
- The company's indebtedness could adversely affect its business and financial condition.
- The company is subject to extensive regulations regarding the use and disclosure of confidential personal information.
Future Outlook
The company expects to maintain a level of cash flows from operating activities sufficient to fund its ongoing and planned business operations and to fund its other liquidity needs.
Management Comments
- Our revenue model is generally success-based as we earn fees based on the aggregate amount of funds that we enable our clients to recover from our services.
- Because our model is based upon the success of our efforts, our business objectives are aligned with those of our clients.
Industry Context
The company operates in the healthcare payment integrity market, which is driven by the need to reduce improper payments and waste in the healthcare system. The company's services are in demand from both government and commercial payers.
Comparison to Industry Standards
- It is difficult to compare Performant Healthcare directly to industry standards without specific competitor data.
- However, companies like Cotiviti and Optum (UnitedHealth Group) also operate in the healthcare payment integrity space.
- These companies often have larger scale and broader service offerings.
- Performant's focus on technology-enabled services and its relationships with CMS and other government agencies are key differentiators.
Legal Proceedings
- The company is involved in various legal proceedings that arise from normal business operations from time to time.
- The company does not expect any such current legal proceedings to have a material adverse impact on its business or financial condition.
Stakeholder Impact
- Shareholders: Positive impact due to improved financial performance.
- Employees: Potential for growth and stability due to increased revenues.
- Customers: Continued service and potential for improved offerings.
- Suppliers: Stable relationships due to improved financial health.
- Creditors: Reduced risk due to improved financial performance.
Next Steps
- Continue to grow the business and expand revenues under commercial healthcare contracts.
- Maintain existing client contracts and expand the client base.
- Manage performance under significant new contracts effectively.
- Continue to improve operational, financial, and management controls, and reporting systems and procedures.
Key Dates
| Date | Description |
|---|---|
| 1976 | Performant Recovery, Inc. (PRI) founded. |
| 1997 | Performant Business Services, Inc. (PBS) founded. |
| 2003 | Performant Healthcare, Inc. formed. |
| 2004 | Performant Technologies, LLC (PTL) formed. |
| 2006 | Tax Relief and Health Care Act of 2006 passed. |
| 2012 | Performant Healthcare, Inc. Amended and Restated 2012 Stock Incentive Plan. |
| 2016 | Center for Medicare and Medicaid Services (CMS) awarded two new Medicare Recovery Audit Contractor (RAC) contracts to Performant Healthcare, Inc. for Regions 1 and 5. |
| 2017 | CMS awarded the national exclusive MSP contract to Performant Healthcare, Inc. |
| 2021 | Performant Healthcare, Inc. was re-awarded the CMS Region 1 contract with a term of eight-and-a-half years. |
| 2022 | Performant Healthcare, Inc. was awarded the RAC contract to audit improper payments for claims made under Medicare Parts A and B in Region 2. |
| 2022 | Performant Healthcare, Inc. was re-awarded the national exclusive MSP contract in December and it has a six-year term. |
| 2022 | Performant Healthcare, Inc. exited the student loan recovery business. |
| 2022 | Management identified a material weakness in the design and operation of information technology general controls (ITGCs) related to user access and program change-management over certain IT systems that support our financial reporting process. |
| 2023-10-27 | Company entered into a credit agreement with Wells Fargo Bank, National Association. |
| 2024-03 | Computer hardware and software included the acquisition of technology assets from a technology company. |
| 2024-12-31 | Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net assets of businesses acquired. |
| 2025-03-31 | End of the quarterly period. |
| 2025-05-08 | The number of shares of Common Stock outstanding as of May 8, 2025 was 78,308,640. |
| 2025-05-09 | Date of report. |
| 2025 | Anticipate services under the New York State Office of the Medicaid Inspector General (OMIG) contract to commence. |
| 2025 | The Region 5 RAC contract expires. |
| 2026-10-27 | The Credit Agreement matures and all outstanding borrowings are due. |
| 2028 | Lease periods expire between 2025 and 2028. |
Keywords
healthcare, revenue, claims-based, eligibility-based, payment integrity, financial results, Q1 2025, Performant Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.